Monday, July 15, 2024

CATEGORY

ICER

ICER Publishes Evidence Report on Anemia Treatment in Myelodysplastic Syndrome

The Institute for Clinical and Economic Review (ICER) has published a revised Evidence Report assessing the comparative clinical effectiveness and value of imetelstat (Rytelo,...

Post-Traumatic Stress Disorder Treatment Lacks Sufficient Evidence for MDMA-Assisted Psychotherapy

The Institute for Clinical and Economic Review (ICER) has published a Final Evidence Report assessing the comparative clinical effectiveness and value of MDMA-assisted psychotherapy...

June 2024 Milestones for Institute for Clinical and Economic Review

In June, the Institute for Clinical and Economic Review (ICER) released a series of significant evaluations and analyses aimed at assessing the effectiveness and...

Institute for Clinical and Economic Review’s May 2024 Updates on Key Assessments of Medical Treatments

In May 2024, the Institute for Clinical and Economic Review (ICER) released several important updates regarding their assessments of various treatments. These assessments are...

Gene Therapies: New Report Highlights Strategies for Managing Costs and Ensuring Access

Gene therapies, which offer revolutionary treatment possibilities for patients with serious conditions like spinal muscular atrophy, hemophilia, and sickle cell disease, have seen remarkable...

Post-Traumatic Stress Disorder Treatment: ICER Criticizes Lykos Therapeutics’ Therapy for Trial Design Issues

The Institute for Clinical and Economic Review (ICER), which usually focuses on the cost-effectiveness of new therapies, has taken an unusual step by sharply...

White Paper on Sustainable Pricing for Gene Therapies Released by ICER and Tufts Medicine

The Institute for Clinical and Economic Review (ICER) and Tufts Medicine's Newdigs initiative have jointly released a comprehensive white paper addressing the critical challenges...

ICER’s Report Reveals $1.3 Billion Surge in U.S. Healthcare Spending

The Institute for Clinical and Economic Review (ICER) has revealed that the price increases of eight specific drugs led to a surge of nearly...

New Era in Drug Pricing: Inflation Reduction Act to Affect High-Cost Drugs

The Inflation Reduction Act (IRA) marks a significant shift in drug pricing, with the Centers for Medicare & Medicaid Services (CMS) in the U.S....

Latest news